• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中的短链脂肪酸:与残疾、T2 病灶数量及炎症特征相关。

Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile.

作者信息

Dominguez-Mozo Maria Inmaculada, López-Mecández Daniel, Villar Luisa María, Costa-Frossard Lucienne, Villarrubia Noelia, Aladro Yolanda, Pilo Belén, Montalbán Xavier, Comabella Manuel, Casanova-Peño Ignacio, González-Suárez Inés, Martínez-Ginés María Luisa, García-Domínguez Jose Manuel, García-Calvo Estefanía, Machuca-Marcos Andrés, Luque-Garcia Jose Luis, Garcia-Martinez María Angel, Arroyo Rafael, Alvarez-Lafuente Roberto

机构信息

Grupo de Investigación de Factores ambientales en enfermedades degenerativas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Red de Enfermedades Inflamatorias (REI), Red Española de Esclerosis Múltiple, Madrid, Spain.

Department of Clinical Analysis, Hospital Clínico San Carlos, Instituto de Medicina del Laboratorio (IML), Madrid, Spain.

出版信息

Ann Clin Transl Neurol. 2025 Mar;12(3):478-490. doi: 10.1002/acn3.52259. Epub 2025 Mar 3.

DOI:10.1002/acn3.52259
PMID:
40033709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11920722/
Abstract

OBJECTIVE

An alteration in the composition of the intestinal microbiota has been observed in patients with multiple sclerosis (pwMS) with respect to healthy controls (HC). Microorganism-derived metabolites such as short-chain fatty acids (SCFA) have been suggested to play a role in the disease. Thus, to analyze the association of SCFA with clinical and radiological parameters of the disease and with those related to the inflammatory response of the immune system.

METHODS

Multicentric observational retrospective cross-sectional study. In addition 161 pwMS and 130 HC were included. The following plasma SCFA were analyzed using liquid chromatography coupled to mass spectrometry: acetate (AA), propionate (PA) and butyrate (BA). Blood cell subpopulations and cytokine expression were analyzed by flow cytometry.

RESULTS

Plasma PA and PA/AA ratio was lower in pwMS than in HC (P = 0.0001, and P = 0.00005, respectively). PA/AA and BA/AA ratios were lower in pwMS with higher disability (P = 0.001, and P = 0.001, respectively). T2 lesion load inversely correlated with PA/AA (r = -0.353; P = 0.002) and BA/AA (r = -0.322; P = 0.005) ratios. Plasma PA/AA and/or BA/AA ratios negatively correlated with the following pro-inflammatory cytokines producing cells: GM-CSF+CD4+T, GM-CSF+CD8+T, TNF-alpha+CD4+T, TNF-alpha+CD8+T, IFN-gamma+CD4+T, IFN-gamma+CD8+T, and TNF-alpha+B cells.

INTERPRETATION

In MS, plasma PA/AA and BA/AA ratios are unbalanced, promoting an environment that could be boosting the mechanisms underlying the pathogenesis of the disease. Since we have found statistical significant associations with the EDSS and the number of T2 lesions, but not with the number of relapses or gadolinium enhancing lesions, PA/AA and BA/AA ratios could be more associated with those mechanisms of the disease related to the neurodegenerative processes than those related with the activity of the disease.

摘要

目的

与健康对照者(HC)相比,已观察到多发性硬化症患者(pwMS)的肠道微生物群组成发生改变。微生物衍生的代谢产物如短链脂肪酸(SCFA)被认为在该疾病中起作用。因此,分析SCFA与该疾病的临床和放射学参数以及与免疫系统炎症反应相关参数之间的关联。

方法

多中心观察性回顾性横断面研究。此外,纳入了161例pwMS患者和130例HC。使用液相色谱-质谱联用分析以下血浆SCFA:乙酸盐(AA)、丙酸盐(PA)和丁酸盐(BA)。通过流式细胞术分析血细胞亚群和细胞因子表达。

结果

pwMS患者的血浆PA和PA/AA比值低于HC(分别为P = 0.0001和P = 0.00005)。残疾程度较高的pwMS患者的PA/AA和BA/AA比值较低(分别为P = 0.001和P = 0.001)。T2病变负荷与PA/AA(r = -0.353;P = 0.002)和BA/AA(r = -0.322;P = 0.005)比值呈负相关。血浆PA/AA和/或BA/AA比值与以下促炎细胞因子产生细胞呈负相关:GM-CSF+CD4+T、GM-CSF+CD8+T、TNF-α+CD4+T、TNF-α+CD8+T、IFN-γ+CD4+T、IFN-γ+CD8+T和TNF-α+B细胞。

解读

在MS中,血浆PA/AA和BA/AA比值失衡,促成了一种可能会促进该疾病发病机制的环境。由于我们发现与扩展残疾状态量表(EDSS)和T2病变数量存在统计学显著关联,但与复发次数或钆增强病变数量无关,因此PA/AA和BA/AA比值可能与该疾病中与神经退行性过程相关的机制比与疾病活动相关的机制更相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/f4216fa47f15/ACN3-12-478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/1635ca8da399/ACN3-12-478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/56f57ffd16ff/ACN3-12-478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/14be36a46bdf/ACN3-12-478-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/f4216fa47f15/ACN3-12-478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/1635ca8da399/ACN3-12-478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/56f57ffd16ff/ACN3-12-478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/14be36a46bdf/ACN3-12-478-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/11920722/f4216fa47f15/ACN3-12-478-g002.jpg

相似文献

1
Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile.多发性硬化症中的短链脂肪酸:与残疾、T2 病灶数量及炎症特征相关。
Ann Clin Transl Neurol. 2025 Mar;12(3):478-490. doi: 10.1002/acn3.52259. Epub 2025 Mar 3.
2
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
3
The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short-Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case-Control Study.1型和2型糖尿病患者与健康对照者的肠道微生物群组成、血清炎症标志物和粪便短链脂肪酸比较:一项病例对照研究。
Endocrinol Diabetes Metab. 2025 Jul;8(4):e70071. doi: 10.1002/edm2.70071.
4
Blood lactate concentrations during rest and exercise in people with Multiple Sclerosis: A systematic review and meta-analysis.多发性硬化症患者静息和运动时的血乳酸浓度:系统评价和荟萃分析。
Mult Scler Relat Disord. 2022 Jan;57:103454. doi: 10.1016/j.msard.2021.103454. Epub 2021 Dec 5.
5
Siponimod for multiple sclerosis.西尼莫德用于多发性硬化症。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013647. doi: 10.1002/14651858.CD013647.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.对首次出现提示多发性硬化症临床发作的患者使用疾病修饰药物进行治疗。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD012200. doi: 10.1002/14651858.CD012200.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

本文引用的文献

1
The role of CD56 NK cells in neurodegenerative disorders.CD56NK 细胞在神经退行性疾病中的作用。
J Neuroinflammation. 2024 Feb 13;21(1):48. doi: 10.1186/s12974-024-03040-8.
2
Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review.肠道微生物群与多发性硬化症的变化:系统评价。
Int J Environ Res Public Health. 2023 Mar 6;20(5):4624. doi: 10.3390/ijerph20054624.
3
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course.多发性硬化症患者和配对的家庭健康对照者的肠道微生物组揭示了与疾病风险和病程的关联。
Cell. 2022 Sep 15;185(19):3467-3486.e16. doi: 10.1016/j.cell.2022.08.021.
4
The role of the gut microbiota in multiple sclerosis.肠道微生物群在多发性硬化症中的作用。
Nat Rev Neurol. 2022 Sep;18(9):544-558. doi: 10.1038/s41582-022-00697-8. Epub 2022 Aug 5.
5
Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study.孕期短链脂肪酸与多发性硬化症:一项前瞻性队列研究。
Eur J Neurol. 2022 Mar;29(3):895-900. doi: 10.1111/ene.15150. Epub 2021 Nov 1.
6
Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity Effects on Th17 Responses.丙酸挽救高脂肪饮食增强的自身免疫中的免疫病理学。对 Th17 反应的影响。
Front Immunol. 2021 Jun 1;12:701626. doi: 10.3389/fimmu.2021.701626. eCollection 2021.
7
Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.血清短链脂肪酸与新诊断多发性硬化症患者和健康对照者炎症的关系。
Front Immunol. 2021 May 6;12:661493. doi: 10.3389/fimmu.2021.661493. eCollection 2021.
8
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids.肠道微生物群衍生的短链脂肪酸对淋巴细胞功能的控制。
Cell Mol Immunol. 2021 May;18(5):1161-1171. doi: 10.1038/s41423-020-00625-0. Epub 2021 Apr 13.
9
Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis.血清短链脂肪酸与多发性硬化症患者循环免疫细胞和血清生物标志物的相关性。
Sci Rep. 2021 Mar 4;11(1):5244. doi: 10.1038/s41598-021-84881-8.
10
Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls.疱疹病毒抗体、维生素 D 和短链脂肪酸:它们与多发性硬化症患者和健康对照者细胞亚群的相关性。
Cells. 2021 Jan 10;10(1):119. doi: 10.3390/cells10010119.